Medicine and Dentistry
Colorectal Cancer
100%
Cohort Analysis
77%
Malignant Neoplasm
64%
Neoplasm
47%
Deep Vein Thrombosis
45%
Venous Thromboembolism
43%
D-Dimer
38%
Symptom
36%
Pancreas Cancer
36%
Pancreas Adenocarcinoma
31%
Cell-Free DNA
30%
Colorectal Carcinoma
30%
Cancer Surgery
29%
Colon Cancer
29%
Promoter Region
29%
Quality of Life
28%
Ileo-Anal Pouch
27%
Prospective Cohort Study
26%
Biological Marker
26%
Recurrent Disease
25%
Sequela
25%
Diseases
25%
Circulating Tumor DNA
25%
Pouchitis
25%
Ulcerative Colitis
25%
Hazard Ratio
23%
Rectum Cancer
23%
Computer Assisted Tomography
22%
Odds Ratio
20%
Fecal Microbiota Transplantation
18%
Phlebothrombosis
18%
Radiation Therapy
18%
Prognostic Factor
18%
Systematic Review
18%
Irreversible Electroporation
18%
Colectomy
18%
Surgery
18%
Overall Survival
17%
Prospective Study
17%
Adjuvant Chemotherapy
16%
Intestine Function
16%
Clinical Trial
15%
Colonoscopy
15%
Anastomosis Leakage
15%
Upper Gastrointestinal Cancer
14%
Randomized Controlled Trial
14%
Mortality Rate
14%
Pelvis
13%
Digestive System Surgery
13%
Cancer Staging
13%
Keyphrases
Colorectal Cancer
20%
Confidence Interval
13%
Colorectal Cancer Patients
13%
SFRP1
13%
Deep Vein Thrombosis
13%
Pancreatic Adenocarcinoma
13%
Plasma D-dimer
12%
Clinical Cohort Study
12%
Chronic Pouchitis
12%
Promoter Methylation
12%
N-3 FA
12%
Intestinal Necrosis
12%
After Surgery
11%
Cell-free DNA (cfDNA)
10%
D-dimer
10%
Oral nutritional Supplements
9%
Postoperative Deep Venous Thrombosis
9%
Bisulfite Treatment
8%
Before Surgery
8%
Blood Biomarkers
8%
DNA Promoter Hypermethylation
8%
Soluble Fibrin
8%
Cumulative Incidence
7%
Gemcitabine
6%
Tumor-informed
6%
Rare Complication
6%
Tackers
6%
Cardiac Tamponade
6%
Hypermethylated DNA
6%
Systemic Glucocorticoids
6%
Laparoscopic Incisional Hernia Repair
6%
Omega-3 Fatty Acids
6%
Chromosome Doubling
6%
Gastroesophageal Adenocarcinoma
6%
Anal Cancer
6%
Colostomy
6%
Preoperative Chemotherapy
6%
Immunomodulation
6%
Anastomotic Complications
6%
Fecal Microbiota Transplantation
6%
Abdominal Surgery
6%
Cancer Outcomes
6%
Pancreaticobiliary Tract
6%
Cancer Prognostics
6%
Biologic Treatment
6%
Benign Disease
6%
Splenic Injury
6%
1-year Survival
6%
Pancreatic Ductal Adenocarcinoma
6%
Right Colectomy
6%
